10x Genomics, Inc.
TXG- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001770787
In the last 90 days, 10x Genomics, Inc. insiders filed 0 open-market purchases and 11 sales; 393 institutions reported holding it in 13F filings for Q2 2026, worth $4.92B in total; superinvestors ARK Invest and Duquesne Family Office hold it.
13F holders, Q3 2024
Institutional positions in 10x Genomics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 266
- +9 vs. Q2 2024
- Shares held
- 104.4M
- +5.68M (+5.8%) vs. Q2 2024
- Total value
- $2.36B
- +$437.1M (+22.8%) vs. Q2 2024
- New holders
- 58
- 103 more added
- Sold out
- 49
- 73 more reduced
4 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 393 | $4.92B |
| Q1 2026 | 332 | $2.66B |
| Q4 2025 | 323 | $2.01B |
| Q3 2025 | 317 | $1.44B |
| Q2 2025 | 297 | $1.42B |
| Q1 2025 | 274 | $995.9M |
| Q4 2024 | 273 | $1.50B |
| Q3 2024 | 266 | $2.36B |
| Q2 2024 | 261 | $2.05B |
| Q1 2024 | 290 | $3.89B |
| Q4 2023 | 275 | $5.37B |
| Q3 2023 | 257 | $3.75B |
| Q2 2023 | 274 | $4.98B |
| Q1 2023 | 259 | $5.03B |
| Q4 2022 | 268 | $3.19B |
| Q3 2022 | 234 | $2.45B |
| Q2 2022 | 254 | $3.91B |
| Q1 2022 | 313 | $6.30B |
| Q4 2021 | 365 | $11.9B |
| Q3 2021 | 332 | $11.5B |
| Q2 2021 | 342 | $15.3B |
| Q1 2021 | 324 | $12.8B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding 10x Genomics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −872−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −606−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −513−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −482−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Tidemark, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Valley National Advisers Inc | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |
| Bradley & Co. Private Wealth Management, LLC | – | – | – | – | Not filed |